Having joined Pfizer in 1995, Aral assumed her current role in September 2024. In 2024, the company had over 32 launches across the MERA region, focusing on oncology offerings and vaccine accessibility. Aral also serves on the IWBD-On Board Women advisory board and is a member of the executive committee for the regional industry association (PHARMEA).